Renal Impaired
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Effect of Severe Renal Impairment on Gilteritinib Compared to Healthy Participants With Normal Renal Function (NCT04699877) | Astellas Pharma Global Development, Inc. | 2021-01-28 |
| Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer (NCT02646358) | Mast Therapeutics, Inc. | 2016-01-01 |
| Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole. (NCT01555866) | Astellas Pharma Global Development, Inc. | 2012-03-01 |
| Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function (NCT01569828) | Novartis Pharmaceuticals | 2009-03-01 |
Track Renal Impaired automatically
Every clearance here is in the API, with alerts when new ones post.